$3.15
0.144.65%
Pre-Market: 4:47 AM EDT
Comments
Loading...
Autolus Therapeutics (AUTL) Forecast
NewsEarningsAutolus Therapeutics (AUTL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAutolus Therapeutics (NASDAQ:AUTL) Stock Quotes, Forecast and News Summary
Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Autolus Therapeutics (AUTL) stock?
You can purchase shares of Autolus Therapeutics (NASDAQ:AUTL) through any online brokerage.
Who are Autolus Therapeutics (AUTL) competitors?
Other companies in Autolus Therapeutics’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Cogent Biosciences (NASDAQ:COGT), Replimune Group (NASDAQ:REPL) and Immatics (NASDAQ:IMTX).
What is the forecast, or price target, for Autolus Therapeutics (AUTL) stock?
Autolus Therapeutics has a consensus price target of $9.31.
What is the current price for Autolus Therapeutics (AUTL)?
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $3.15 last updated November 15, 2024 at 4:47 AM EST.
Does Autolus Therapeutics (AUTL) pay a dividend?
There are no upcoming dividends for Autolus Therapeutics.
When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?
Autolus Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Autolus Therapeutics (AUTL) going to split?
There is no upcoming split for Autolus Therapeutics.
What sector and industry does Autolus Therapeutics (AUTL) operate in?
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.